Skip to main content

Day: May 11, 2022

HeartCore Signs Agreements with Two Clients for its Go IPO Consulting Service

NEW YORK and TOKYO, May 11, 2022 (GLOBE NEWSWIRE) — HeartCore Enterprises, Inc., (“HeartCore” or “the Company”), a leading software development company, announced that it has signed agreements with two companies for its recently announced Go IPO consulting service. After just one month of launching this new consulting service, HeartCore was able to engage two private companies that intend to go public on the Nasdaq Stock Market (“Nasdaq”), Moveaction Co., Ltd. (“Moveaction”) and A.L.I. Technologies Inc. (“A.L.I. Technologies”). Through Go IPO, the Company will service those and other clients by assisting throughout the audit and legal firm hiring process, translating requested documents into English, providing general support services, assisting in the preparation of the S-1 or F-1 filing, and more. As compensation for its services,...

Continue reading

Skylight Health Announces Earnings Call and Corporate Update

TORONTO, May 11, 2022 (GLOBE NEWSWIRE) — Skylight Health Group Inc. (NASDAQ:SLHG;TSXV:SLHG (“Skylight Health” or the “Company”), a multi-state primary care management group in the United States, today announced that its financial results for the first quarter of 2022 will be released after the close of market on May 16th, 2022. The Company will host a conference call at 8:00am EDT on the morning of May 17th, 2022 to discuss the financial results and outlook for the Company. If you would like to participate in the call, details can be found below. Please dial in approximately 10 minutes prior to the start of the call. Conference Call DetailsDate: May 17, 2022Time: 8:00am EasternUS/Canada Toll Free Dial In: 1-800-319-4610Toronto Local Dial In: 416-915-3239International Dial In: +1-604-638-5340Call Name: Skylight...

Continue reading

Mandalay Resources Corporation Announces Financial Results for the First Quarter 2022

TORONTO, May 11, 2022 (GLOBE NEWSWIRE) — Mandalay Resources Corporation (“Mandalay” or the “Company”) (TSX: MND, OTCQB: MNDJF) is pleased to announce its financial results for the quarter ended March 31, 2022. The Company’s condensed and consolidated interim financial results for the quarter ended March 31, 2022, together with its Management’s Discussion and Analysis (“MD&A”) for the corresponding period, can be accessed under the Company’s profile on www.sedar.com and on the Company’s website at www.mandalayresources.com. All currency references in this press release are in U.S. dollars except as otherwise indicated. First Quarter 2022 Highlights:Net debt free, with $50.4 million of cash on hand and $45.7 million in total interest-bearing debt outstanding; Quarterly revenue of $54.2 million, second highest since Q2 2016; $28.0...

Continue reading

Interfor Reports Q1’22 Results

Adjusted EBITDA of $570 million and Net Earnings of $397 millionWith Record Production BURNABY, British Columbia, May 11, 2022 (GLOBE NEWSWIRE) — INTERFOR CORPORATION (“Interfor” or the “Company”) (TSX: IFP) recorded Net earnings in Q1’22 of $397.0 million, or $6.69 per share, compared to $69.7 million, or $1.15 per share in Q4’21 and $264.5 million, or $4.01 per share in Q1’21. Adjusted net earnings in Q1’22 were $392.5 million compared to $78.2 million in Q4’21 and $270.6 million in Q1’21. Adjusted EBITDA was $570.1 million on sales of $1.3 billion in Q1’22 versus $149.5 million on sales of $675.9 million in Q4’21. Notable items in the quarter:Acquisition of EACOM Timber CorporationOn February 22, 2022, the Company completed the transaction to acquire 100% of the equity interests of EACOM Timber Corporation (“EACOM”) from...

Continue reading

Savaria Presents Q1 2022 Results: Revenue of $184 million and 12% Organic Growth

LAVAL, Québec, May 11, 2022 (GLOBE NEWSWIRE) — Savaria Corporation (“Savaria”) (TSX: SIS), a global leader in the accessibility industry, is pleased to announce its results for the first quarter of fiscal 2022. Highlights – Q1 2022 compared to Q1 2021Revenue for the quarter was $183.5M, up $71.5M or 63.8%, mainly due to the acquisition of Handicare in March 2021 and organic growth in the Accessibility and Patient Care segments.Gross profit was $58.5M, up $21.1M or 56.5%, representing 31.9% of revenue compared to 33.4% in Q1 2021. Operating income was $8.8M, up $2.4M or 38.4%, representing 4.8% of revenue compared to 5.7% in Q1 2021. Adjusted EBITDA was $24.4M, up $7.1M or 41.2%. Adjusted EBITDA margin stood at 13.3%, down 2.1% compared to 15.4% in Q1 2021. Net earnings for the quarter were $5.3M, or $0.08, per share on a diluted...

Continue reading

AirBoss Announces Record First Quarter 2022 Results

NEWMARKET, Ontario, May 11, 2022 (GLOBE NEWSWIRE) — AirBoss of America Corp. (TSX: BOS) (the “Company” or “AirBoss”) today announced strong first quarter performance as it has entered 2022 with continued momentum. The Company’s annual general meeting will be held on Thursday, May 12th, 2022, at 9:00 a.m. (EDT). Following the formal portion of the meeting, management will provide a presentation including a discussion of Q1 2022 results. In an effort to safeguard the health of its shareholders, directors, management and employees, the meeting will be accessible via live webcast or by dialing in to the numbers provided later in this release. All dollar amounts are shown in thousands of United States dollars (“U.S. $” or “$”), except per share amounts, unless otherwise noted. Recent HighlightsDiluted EPS growth...

Continue reading

Black Diamond Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Update

Dosed first patient in Phase 1 Study of BDTX-1535 for the treatment of glioblastoma multiforme (GBM) and non-small cell lung cancer (NSCLC) including those with central nervous system (CNS) tumors; clinical update expected in 2023 Continued strategic focus on development of BDTX-1535, BDTX-4933 and MAP drug discovery engine enabled small molecule drug discovery efforts Financial position strengthened and cash runway extended into third quarter of 2024; cash, cash equivalents, and investments of approximately $179.7 million as of March 31, 2022CAMBRIDGE, Mass. and NEW YORK, May 11, 2022 (GLOBE NEWSWIRE) — Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology medicine company pioneering the discovery and development of MasterKey therapies, today reported financial results for the first quarter ended March 31,...

Continue reading

STERIS Announces Financial Results for Fiscal 2022 Fourth Quarter and Full Year

Fourth quarter revenue increases 39% as reported; 11% constant currency organic As reported EPS of $0.52; adjusted EPS of $2.04 Company provides FY23 outlookDUBLIN, IRELAND, May 11, 2022 (GLOBE NEWSWIRE) —  STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2022 fourth quarter ended March 31, 2022. Revenue as reported for the quarter increased 39% to $1.2 billion compared with $873.5 million in the fourth quarter of fiscal 2021. Constant currency organic revenue (see Non-GAAP Financial Measures) increased 11% for the fourth quarter of fiscal 2022 as compared to the fourth quarter of fiscal 2021.   “We are pleased to end the year with strong performance in the fourth quarter, as our balanced revenue stream continues to deliver solid growth in the current environment,” said Dan...

Continue reading

Summit Therapeutics Inc Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2022

Cambridge, MA, May 11, 2022 (GLOBE NEWSWIRE) — Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) today reports its financial results and provides an update on operational progress for the first quarter ended March 31, 2022. Note: A glossary of terms is included at the end of this document to allow for the ease of understanding of terms or concepts used throughout this release. Financial HighlightsAggregate cash, accounts receivable, and tax credits receivable on March 31, 2022 totaled $95.3 million as compared to $89.0 million on December 31, 2021. Our cash balance on March 31, 2022 was $77.5 million as compared to $71.8 million on December 31, 2021. Accounts receivable and research and development tax credits receivable on March 31, 2022 were $17.8 million as compared...

Continue reading

Freshii Inc. Announces First Quarter 2022 Results and Executive Changes

        Daniel Haroun promoted to CEO of Freshii Inc.; Founder Matthew Corrin becomes Executive ChairmanVictor Diab to join the Company as CFOQ1 2021 Company-wide revenue up 162% vs. prior year, driven by growth across all business lines and Natura Market acquisitionNorth American franchised restaurant development pipeline of committed locations reaches over 100 units with more than 90% from existing franchiseesNorth American Franchised Restaurant Segment records Q1 2022 System sales growth1 of 11% and Franchise Revenue growth of 10% vs Q1 2021Natura Market records 6% revenue growth vs. the corresponding period in 20212CPG business records CPG system sales growth of 85% in Q1 2022 vs. Q1 2021 TORONTO, May 11, 2022 (GLOBE NEWSWIRE) — Omnichannel health and wellness brand, Freshii Inc. (TSX: FRII) (“Freshii”, the “Company”, “us”,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.